Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus
David W. Hutton, Lisa A. Prosser, Angela M. Rose, Kerra Mercon, Ismael R. Ortega‐Sanchez, Andrew J. Leidner, Fiona P. Havers, Mila M. Prill, Michael Whitaker, Lauren E. Roper, Jamison Pike, Amadea Britton, Michael Melgar
Topics & Concepts
VirusMedicineVirologyRespiratory systemCost effectivenessPneumovirusImmunologyParamyxoviridaeViral diseaseInternal medicineRisk analysis (engineering)Respiratory viral infections researchInfluenza Virus Research StudiesViral gastroenteritis research and epidemiology